Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Long-Term Investments: 2021-2022

Historic Long-Term Investments for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2022 value amounting to $7.6 million.

  • ADC Therapeutics' Long-Term Investments fell 22.19% to $27.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.0 million, marking a year-over-year decrease of 22.19%. This contributed to the annual value of $7.6 million for FY2022, which is 81.54% down from last year.
  • Per ADC Therapeutics' latest filing, its Long-Term Investments stood at $7.6 million for FY2022, which was down 81.54% from $41.2 million recorded in FY2021.
  • ADC Therapeutics' 5-year Long-Term Investments high stood at $41.2 million for FY2021, and its period low was $7.6 million during FY2022.
  • Its 2-year average for Long-Term Investments is $24.4 million, with a median of $24.4 million in 2021.
  • Data for ADC Therapeutics' Long-Term Investments shows a maximum YoY tumbled of 81.54% (in 2022) over the last 5 years.
  • ADC Therapeutics' Long-Term Investments (Yearly) stood at $41.2 million in 2021, then crashed by 81.54% to $7.6 million in 2022.